This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Altria (MO) Stock Moves -0.67%: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.93, marking a -0.67% move from the previous day.
Altria (MO) Rises Higher Than Market: Key Facts
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $43.66, representing a +1.25% change from its previous close.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Altria (MO) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $44.95, representing a +0.36% change from its previous close.
Altria (MO) Gains on Pricing Power & Smoke-Free Strength
by Zacks Equity Research
Altria (MO) benefits from its pricing power and focus on smoke-free products amid soft cigarette volumes.
Why Altria (MO) Dipped More Than Broader Market Today
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $43.87, moving -0.93% from the previous trading session.
Altria (MO) Ups Earnings View, Expands Share Buyback Plans
by Zacks Equity Research
Altria (MO) divests 35 million shares of Anheuser-Busch InBev. Management expands share repurchase plans while raising the bottom-line view for 2024.
Altria (MO) Plans to Sell Partial Stake in Anheuser-Busch InBev
by Zacks Equity Research
Altria (MO) reveals intentions to divest a portion of its stake in Anheuser-Busch InBev SA/NA via a global secondary offering.
Altria (MO) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $43.35, moving +0.7% from the previous trading session.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria (MO) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $41.55, representing a +0.24% change from its previous close.
Altria (MO) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $40.86, denoting a -0.12% change from the preceding trading day.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
by Zacks Equity Research
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Share Buybacks: 5 Companies Scooping Up Shares
by Derek Lewis
Buybacks can provide a nice confidence boost for investors, indicating that the company is utilizing excess cash and helping put in a floor for shares.
Zacks Industry Outlook Highlights Philip Morris International, Altria and 22nd Century Group
by Zacks Equity Research
Philip Morris International, Altria and 22nd Century Group are part of the Zacks Industry Outlook article.
3 Tobacco Stocks Grabbing Attention on Solid Industry Trends
by Vrishali Bagree
The Zacks Tobacco industry companies have been benefiting from their pricing power and strength in smoke-free products amid an inflationary landscape. These upsides keep Philip Morris (PM), Altria Group (MO) and 22nd Century Group (XXII) well-placed.
3 Stocks to Buy out of the Top-Rated Zacks Diversified Operations Industry
by Shaun Pruitt
The growth prospects of these Zacks Diversified Operations Industry stocks are very intriguing considering their reasonable valuations.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Zacks Investment Ideas feature highlights: QQQ, Altria, Dollar General, Walmart and Costco Wholesale
by Zacks Equity Research
QQQ, Altria, Dollar General, Walmart and Costco Wholesale are part of the Zacks Investment Ideas article.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Volatility Ahead? 3 Ways to Tame it
by Andrew Rocco
As investors navigate the dynamic landscape of Wall Street, the certainty of volatility becomes apparent. Stock Strategist Andrew Rocco explains 3 ways to combat volatility.
Altria's (MO) Q4 Earnings Top Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Altria's (MO) fourth-quarter 2023 results reflect lower cigarette shipment volumes as a result of macroeconomic pressure on ATC behavior. However, pricing remains an upside.
Altria (MO) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Altria (MO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Altria (MO) Q4 Earnings Beat Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 0.85% and 1.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?